Axsome Therapeutics, Inc. (NASDAQ:AXSM), is a clinical stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders.
Axsome Therapeutics, Inc.
[stock_market_widget type=”leaderboard” template=”color-frame” color=”yellow” assets=”AXSM” api=”yf” style=”font-size: 15px”]
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttps://axsome.com
Disease Focus
Development Stage
STOCK CODENASDAQ: AXSM
Address25 Broadway, 9th Floor, NY 10004New YorkUnited States
25 Broadway, 9th Floor, NY 10004
New York
United States
Contact Number+1 212-332-3241
+1 212-332-3241
Axsome Therapeutics, Inc. (NASDAQ:AXSM), is a clinical stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders.
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/axsome-therapeutics-inc-” connections=”true” suffix=””]
As per discloser, Axsome Therapeutics, was having $48.0 million of cash as of December 31, 2015 to fund the clinical development of its two major programs.